热稳定支架佐剂的猴痘纳米疫苗候选物可诱导快速且高效的体液免疫应答
本研究以大肠杆菌表达并纯化三种猴痘病毒保护性抗原L1、A29、A33及热稳定Aquafex aeolicus lumazine synthase(AaLS),经偶联制备纳米疫苗候选物。热稳定性试验显示纳米疫苗在37℃存放一周不变、60℃仅部分降解;单剂免疫即可诱导高效抗体应答,两剂可诱导持续2个月的高滴度抗体;体外病毒中和试验显示纳米疫苗候选物诱导的中和抗体水平显著高于单体抗原。作者认为AaLS偶联的MPXV抗原纳米疫苗在储存和抗原性方面高度热稳定,是该再发疾病良好的替代疫苗候选物。
要点
- MPXV抗原L1、A29、A33与热稳定AaLS偶联制备纳米疫苗候选物。
- 纳米疫苗37℃存放一周不变、60℃仅部分降解,显示高热稳定性。
- 单剂即诱导高效抗体应答,两剂诱导2个月高滴度抗体,中和抗体显著高于单体。
核心结论
- AaLS偶联的MPXV抗原纳米疫苗在储存和抗原性方面高度热稳定,是该再发疾病良好的替代疫苗候选物。
研究设计与样本
- 以大肠杆菌表达并经Ni-NTA法纯化MPXV保护性抗原L1、A29、A33及热稳定AaLS,将抗原与AaLS偶联制备纳米疫苗候选物。
主要发现
- 热稳定性试验显示纳米疫苗在37℃存放一周后保持不变,在60℃下仅部分降解。
- 单剂免疫即可诱导高效抗体应答,两剂免疫诱导持续2个月的高滴度抗体。
- 体外病毒中和试验显示纳米疫苗候选物诱导的中和抗体水平显著高于单体抗原。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Monkeypox (mpox) is a zoonotic disease caused by monkeypox virus (MPXV) of the orthopoxvirus genus. The emergence and global spread of mpox in 2022 was declared as a public health emergency by World Health Organization. This mpox pandemic alarmed us that mpox still threaten global public health. Live vaccines could be used for immunization for this disease with side effects. New alternative vaccines are urgently needed for this re-emerging disease. Specific antibody responses play key roles for protection against MPXV, therefore, vaccines that induce high humoral immunity will be ideal candidates. In the present study, we developed thermostable nanovaccine candidates for mpox by conjugating MPXV antigens with thermostable nanoscafolds. Three MPXV protective antigens, L1, A29, and A33, and the thermostable Aquafex aeolicus lumazine synthase (AaLS), were expressed in E. coli and purified by Ni-NTA methods. The nanovaccines were generated by conjugation of the antigens with AaLS. Thermal stability test results showed that the nanovaccines remained unchanged after one week storage under 37℃ and only partial degradation under 60℃, indicating high thermostability. Very interesting, one dose immunization with the nanovaccine could induce high potent antibody responses, and two dose induced 2-month high titers of antibodes. In vitro virus neutralization test showed that nanovaccine candidates induced significantly higher levels of neutralization antibodies than monomers. These results indicated that the AaLS conjugation nanovaccines of MPXV antigens are highly thermostable in terms of storage and antigenic, being good alternative vaccine candidates for this re-emerging disease.
引用
- Yan H, Peng Y, Zhang J, et al. Rapid and highly potent humoral responses to mpox nanovaccine candidates adjuvanted by thermostable scaffolds. Vaccine. 2024. PMID: 38423815. doi:10.1016/j.vaccine.2024.02.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。